Form 8-K - Current report:
SEC Accession No. 0001839882-23-034226
Filing Date
2023-12-20
Accepted
2023-12-20 10:31:30
Documents
57
Period of Report
2023-12-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_122023.htm   iXBRL 8-K 80920
2 PRESS RELEASE ex99-01.htm EX-99.01 108996
3 INVESTOR PRESENTATION BY THE COMPANY ex99-02.htm EX-99.02 59134
7 GRAPHIC ex99-02_img01.jpg GRAPHIC 164672
8 GRAPHIC ex99-02_img02.jpg GRAPHIC 244987
9 GRAPHIC ex99-02_img03.jpg GRAPHIC 238255
10 GRAPHIC ex99-02_img04.jpg GRAPHIC 167778
11 GRAPHIC ex99-02_img05.jpg GRAPHIC 180162
12 GRAPHIC ex99-02_img06.jpg GRAPHIC 140935
13 GRAPHIC ex99-02_img07.jpg GRAPHIC 127629
14 GRAPHIC ex99-02_img08.jpg GRAPHIC 148722
15 GRAPHIC ex99-02_img09.jpg GRAPHIC 153306
16 GRAPHIC ex99-02_img10.jpg GRAPHIC 144447
17 GRAPHIC ex99-02_img11.jpg GRAPHIC 139224
18 GRAPHIC ex99-02_img12.jpg GRAPHIC 140709
19 GRAPHIC ex99-02_img13.jpg GRAPHIC 133724
20 GRAPHIC ex99-02_img14.jpg GRAPHIC 169474
21 GRAPHIC ex99-02_img15.jpg GRAPHIC 120580
22 GRAPHIC ex99-02_img16.jpg GRAPHIC 180898
23 GRAPHIC ex99-02_img17.jpg GRAPHIC 195212
24 GRAPHIC ex99-02_img18.jpg GRAPHIC 140387
25 GRAPHIC ex99-02_img19.jpg GRAPHIC 156824
26 GRAPHIC ex99-02_img20.jpg GRAPHIC 144422
27 GRAPHIC ex99-02_img21.jpg GRAPHIC 161546
28 GRAPHIC ex99-02_img22.jpg GRAPHIC 200233
29 GRAPHIC ex99-02_img23.jpg GRAPHIC 120348
30 GRAPHIC ex99-02_img24.jpg GRAPHIC 140846
31 GRAPHIC ex99-02_img25.jpg GRAPHIC 168177
32 GRAPHIC ex99-02_img26.jpg GRAPHIC 182929
33 GRAPHIC ex99-02_img27.jpg GRAPHIC 167588
34 GRAPHIC ex99-02_img28.jpg GRAPHIC 165930
35 GRAPHIC ex99-02_img29.jpg GRAPHIC 191847
36 GRAPHIC ex99-02_img30.jpg GRAPHIC 96215
37 GRAPHIC ex99-02_img31.jpg GRAPHIC 107638
38 GRAPHIC ex99-02_img32.jpg GRAPHIC 141244
39 GRAPHIC ex99-02_img33.jpg GRAPHIC 137300
40 GRAPHIC ex99-02_img34.jpg GRAPHIC 174080
41 GRAPHIC ex99-02_img35.jpg GRAPHIC 104202
42 GRAPHIC ex99-02_img36.jpg GRAPHIC 165452
43 GRAPHIC ex99-02_img37.jpg GRAPHIC 210474
44 GRAPHIC ex99-02_img38.jpg GRAPHIC 127045
45 GRAPHIC ex99-02_img39.jpg GRAPHIC 151130
46 GRAPHIC ex99-02_img40.jpg GRAPHIC 159034
47 GRAPHIC ex99-02_img41.jpg GRAPHIC 150628
48 GRAPHIC tnxp-8k_img01.jpg GRAPHIC 161651
49 GRAPHIC ex99-01_img01.jpg GRAPHIC 56069
  Complete submission text file 0001839882-23-034226.txt   9817973

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20231220.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20231220_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20231220_pre.xml EX-101.PRE 22365
51 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_122023_htm.xml XML 5140
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 231500077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)